Related Experiment Video

Updated: May 13, 2026

Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
06:08

Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator

Published on: May 19, 2023

Prednisolone induces the Wnt signalling pathway in 3T3-L1 adipocytes

Wilco W M Fleuren1, Margot M L Linssen, Erik J M Toonen

  • 1CDD, CMBI, NCMLS, Radboud University Medical Centre, Nijmegen, The Netherlands.

Archives of Physiology and Biochemistry
|March 20, 2013
PubMed

Insights

Synthetic glucocorticoids like prednisolone cause metabolic side effects, including insulin resistance. This study reveals prednisolone disrupts Wnt signaling and immune responses in fat cells, offering targets for safer anti-inflammatory drugs.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Synthetic glucocorticoids are effective anti-inflammatory drugs.
  • However, they cause dose-dependent metabolic side effects, including insulin resistance and obesity.
  • The exact mechanisms, particularly adipose tissue involvement, remain unclear.

Purpose of the Study:

  • To investigate prednisolone-induced changes in gene expression and adipokine secretion in 3T3-L1 adipocytes.
  • To identify molecular pathways underlying glucocorticoid-induced metabolic dysfunction.
  • To explore potential therapeutic targets for mitigating side effects.

Main Methods:

  • Transcriptomics analysis to assess gene expression.
  • Antibody arrays to measure adipokine secretion.
  • Bioinformatics to analyze molecular pathways.
  • Utilized 3T3-L1 adipocyte model.

Main Results:

  • Prednisolone significantly altered gene expression and adipokine secretion in adipocytes.
  • Key pathways regulated by prednisolone include cytokine signaling, Akt signaling, and Wnt signaling.
  • Dysregulation of Wnt signaling and immune response pathways were identified.

Conclusions:

  • Prednisolone induces insulin resistance through mechanisms involving Wnt signaling and immune response pathways.
  • These pathways represent potential targets for developing glucocorticoids with reduced metabolic side effects.
  • Further research into these pathways could lead to improved anti-inflammatory therapies.

Related Concept Videos

Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...